SEC Company Filings

Chemomab Completes Merger with Anchiano Therapeutics (READ MORE) (March 16, 2021)

Contact:

Investor Relations: Irina Koffler, LifeSci Advisors, LLC

Phone: +1-917-734-7387         

Email: ir@chemomab.com

Chemomab Therapeutics: Sharon Elkobi, VP, Business Development

Phone: +972773310156

Email: bd@chemomab.com

Visit Chemomab online at www.chemomab.com

Anchiano Therapeutics Ltd. CIK#: 0001534248 (link to EDGAR)


Filing DateForm (Link to docs.)DescriptionDownload
21-03-178-KCurrent report, items 1.01, 2.01, 3.02, 3.03, 5.01, 5.02, 5.03, 5.07, and 9.01PDF
21-03-108-KCurrent report, item 8.01PDF
21-03-10425Prospectuses and communications, business combinationsPDF
21-03-0910-KAnnual report [Section 13 and 15(d), not S-K Item 405]PDF
21-03-09425Prospectuses and communications, business combinationsPDF
21-02-12424B3Prospectus [Rule 424(b)(3)]PDF
21-02-10EFFECTNotice of EffectivenessPDF
21-02-10S-4/ARegistration of securities, business combinations [Amend] PDF
21-02-088-KCurrent report, item 8.01PDF
21-02-08425Prospectuses and communications, business combinationsPDF
21-02-02425Prospectuses and communications, business combinationsPDF
21-01-13S-4Registration of securities, business combinationsPDF
21-01-11425Prospectuses and communications, business combinationsPDF
21-01-05425Prospectuses and communications, business combinationsPDF
20-12-158-KCurrent report, items 1.01, 8.01, and 9.01PDF
20-12-15DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialPDF
20-11-1610-QQuarterly report [Sections 13 or 15(d)]PDF
20-10-208-KCurrent report, item 5.02PDF
20-08-1410-QQuarterly report [Sections 13 or 15(d)]PDF
20-07-158-KCurrent report, item 5.02PDF
20-07-098-KCurrent report, items 5.02 and 8.01PDF
20-05-218-KCurrent report, item 5.02PDF
20-05-0710-QQuarterly report [Sections 13 or 15(d)]PDF
20-05-068-KCurrent report, items 5.02, 7.01, and 9.01PDF
20-04-248-KCurrent report, item 5.07PDF
20-04-17DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialPDF
20-04-158-KCurrent report, item 3.01PDF
20-03-30Pre 14AOther preliminary proxy statementsPDF
20-03-17S-8Securities to be offered to employees in employee benefit plansPDF
20-03-1710-KAnnual report [Section 13 and 15(d), not S-K Item 405]PDF
20-03-168-KCurrent report, item 8.01PDF
20-02-108-KCurrent report, items 5.02 and 8.01PDF
20-02-048-KCurrent report, items 2.05, 7.01, and 9.01PDF
20-01-318-KCurrent report, item 8.01PDF
20-01-108-KCurrent report, item 8.01PDF
20-01-028-KCurrent report, items 5.02 and 8.01PDF
19-11-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-11-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-10-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-08-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-07-22S-8Securities to be offered to employees in employee benefit plansPDF
19-07-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-05-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-05-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-04-2420-F/AAnnual and transition report of foreign private issuers [Sections 13 or 15(d)] [Amend] PDF
19-03-2520-KAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]PDF
19-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-02-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-02-13424B4Prospectus [Rule 424(b)(4)]PDF
19-02-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-02-11F-1/ARegistration statement for certain foreign private issuers [Amend] PDF
19-02-088-A12BRegistration of securities [Section 12(b)]PDF
19-02-08F-1/ARegistration statement for certain foreign private issuers [Amend] PDF
19-02-07F-1/ARegistration statement for certain foreign private issuers [Amend] PDF
19-01-30F-1/ARegistration statement for certain foreign private issuers [Amend] PDF
19-01-07F-1Registration statement for certain foreign private issuers PDF